The legal position of the medical representative

The Measures for the Administration of Medical Representative Registration (2021) defines the medical representative's statutory role: a professional conveying drug information, communication and feedback — not a salesperson. This is a fundamental shift.

  • Convey safety and efficacy information to healthcare professionals
  • Collect and feed back clinical-use and adverse-reaction information
  • Prohibited from undertaking drug sales tasks — the core prohibition
  • Prohibited from counting doctors' prescriptions
  • Prohibited from paying healthcare professionals any reward in exchange for prescriptions

The core target of the 2023 campaign: performance pay tied to prescription volume — companies calculating reps' bonuses by the prescriptions of the hospitals/doctors they cover — is treated as the institutionalised form of "kickback-driven selling". Many companies have been forced to reform their sales-incentive schemes. We recommend immediately reviewing current incentive plans to strip out any metric directly or indirectly linked to prescription volume.

The registration (filing) system

  • Who files: the MAH files its medical representatives on the designated NMPA platform.
  • Information: name, photo, MAH, promoted products and territories.
  • Changes and de-registration: the MAH must update within 30 days of departure, territory or product changes.
  • Doctors' verification right: healthcare professionals may verify a rep's registration and refuse unregistered or mismatched reps.

SOPs for academic-promotion activities

Academic promotion is the rep's core work, but the line between "academic promotion" and "disguised benefit transfer" is not always clear. We recommend standardised SOPs covering:

Academic visits

  • Reasonable limits on frequency and duration (e.g. 2–4 times per doctor per month, ≤15 minutes each)
  • Visits in public or designated academic areas, not disrupting clinical work
  • No gifts, samples (except where law permits) or hospitality
  • A record of each visit — who, topic and duration

Organising and sponsoring meetings

  • A genuine academic agenda and qualified speakers
  • Appropriate venues matching the academic nature — not luxury resorts or golf courses
  • Reasonable, moderate travel and accommodation support for attendees
  • Speaker fees at clear, fair-market rates, with a written agreement, actual delivery and tax withholding
  • Working meals, not lavish banquets

Speaker fees — the highest-risk area

Speaker fees are the most common — and most easily breached — aspect of HCP interaction. Legitimate fees vs. disguised kickbacks:

  • ✓ Legitimate: genuine expertise and qualification, academically valuable content, market-consistent amount, written agreement, actual delivery, tax withholding and book-recorded payment.
  • ✗ Disguised kickback: speaker on paper only, grossly inflated fees, fees correlated with prescribing volume, or fees without tax withholding.

Responding to regulatory investigation

  • Dawn-raid contingency planning and staff training
  • Real-time legal advice during investigations (enforcement authority and company rights)
  • Evidence collection and legal assessment
  • Administrative-stage responses — hearings, statements and remediation commitments
  • Criminal-defence strategy after formal filing